Drug Wholesaler Settles FCA Suit For $625M
By the C|C Whistleblower Lawyer Team
AmerisourceBergen, a Pennsylvania-based company that provides drug distribution and related services, has agreed to pay
$625M to settle an FCA case that claimed that a pre-filled syringe program at one of its subsidiaries violated several federal laws. The subsidiary, Medical Initiatives Inc. (MII), closed in 2014, but was responsible for moving cancer medications from glass...